Prostate Cancer - Results from #25340

Prostate cancer - A biomarker perspective - Abstract July 25, 2012

Toward maximizing immunotherapy in metastatic castration-resistant prostate cancer - Rationale for combinatorial approaches using chemotherapy - Abstract July 25, 2012

Applicability of robot-assisted laparoscopic radical prostatectomy in renal allograft recipients - Abstract July 25, 2012

Comparison of serum testosterone levels in prostate cancer patients receiving LHRH agonist therapy with or without the removal of the prostate - Abstract July 25, 2012

Prostate cancer screening: Attitudes and practices of family physicians in Ontario - Abstract July 25, 2012

Prostate Cancer Localization using Multiparametric MRI based on Semi-supervised Techniques with Automated Seed Initialization - Abstract July 25, 2012

Spironolactone, a possible selective androgen receptor modulator, should be used with caution in patients with metastatic carcinoma of the prostate - Abstract July 25, 2012

Successful treatment of advanced metastatic prostate cancer following chemotherapy based on molecular profiling - Abstract July 25, 2012

Prognostic significance of primary Gleason pattern in Japanese men with Gleason score 7 prostate cancer treated with radical prostatectomy - Abstract July 24, 2012

Prostate-specific membrane antigen-based imaging - Abstract July 24, 2012

Prostatic needle biopsies following primary high intensity focused ultrasound (HIFU) therapy for prostatic adenocarcinoma: histopathological features in tumour and non-tumour tissue - Abstract July 24, 2012

[Are therapeutics decisions homogeneous in multidisciplinary onco-urology staff meeting? Comparison of therapeutic options taken in four departments from Paris] - Abstract July 24, 2012

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer - Abstract July 24, 2012

Intensity Modulated Radiation Therapy Dose Painting for Localized Prostate Cancer Using (11)C-choline Positron Emission Tomography Scans - Abstract July 24, 2012

Acute Radiation-Induced Nocturia in Prostate Cancer Patients Is Associated With Pretreatment Symptoms, Radical Prostatectomy, and Genetic Markers in the TGFβ1 Gene - Abstract July 24, 2012

Early Salvage Hormonal Therapy for Biochemical Failure Improved Survival in Prostate Cancer Patients After Neoadjuvant Hormonal Therapy Plus Radiation Therapy-A Secondary Analysis of Irish Clinical Oncology Research Group 97-01 - Abstract July 24, 2012

Serum Testosterone and Dihydrotestosterone and Prostate Cancer Risk in the Placebo Arm of the Reduction by Dutasteride of Prostate Cancer Events Trial - Abstract July 24, 2012

BJUI Mini Reviews - PCA: Prostate cancer, patient-centred approach or both? July 24, 2012

Radiation treatment for patients with intermediate-risk prostate cancer - Abstract July 23, 2012

Management of biochemical recurrence after primary localized therapy for prostate cancer - Abstract July 23, 2012

Page 1268 of 1436